Yanda International Hospital
Crohn's disease treatment cost in China typically includes essential diagnostics like gastroscopy with biopsy, which ranges from Price on request to Price on request , and biochemical blood analysis from Price on request to Price on request . Primary medical interventions such as hormone therapy cost Price on request to Price on request . Total expenses depend on the need for biologics, surgical stays, and outpatient maintenance requirements. Patients can expect 30-50% savings compared to the US. Top cities for this treatment include Beijing and Shanghai.
Typical Crohn's Disease Treatment Costs in China
Bookimed Expert Insight: Early tumor screening and accurate staging are best managed by specialized gastroenterologists. Dr. Sun Guanxi in Shanghai brings experience from thousands of endoscopic procedures for precise diagnosis. For complex cases requiring inpatient care, Yanda International Hospital in Beijing offers Joint Commission International (JCI) accredited Class A level III facilities. This high-tier clinical environment is ideal for international patients seeking western-standard hospital safety and multidisciplinary care.
No hidden fees – just official clinic prices. Pay at the clinic for Crohn's disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Crohn's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Crohn's disease treatment journey.
Dr. Sun Guangxi is a gastroenterologist at Shanghai Tongji Hospital. He has performed thousands of painless gastroscopy and colonoscopy procedures. He specializes in the early detection and minimally invasive treatment of digestive cancers. Dr. Sun is a member of the Chinese Medical Association’s Digestive Endoscopy Society.
Dr. Wang He Tian is the Head of Traditional Chinese Medicine at Yanda International Hospital. He is a leading expert in the inheritance of Chinese medical academic experience. Dr. Wang has authored over 10 clinical books on traditional medicine. He treats complex conditions like chronic inflammation and female infertility at a JCI-accredited facility.
Top Chinese hospitals for Crohn’s disease treatment include Peking Union Medical College Hospital and Yanda International Hospital. These JCI-accredited facilities use multidisciplinary teams and advanced biologics. Many centers integrate Western medicine with traditional protocols. Specialized inflammatory bowel disease units manage complex cases across Beijing, Shanghai, and Guangzhou.
Bookimed Expert Insight: Yanda International Hospital stands out by combining international JCI standards with traditional Chinese medicine for chronic inflammation. While many national centers focus strictly on Western protocols, this integrated approach serves over 2,500,000 patients annually. The clinic is particularly accessible for international patients, offering dedicated services for Arabic and Russian speakers.
Patient Consensus: Patients recommend focusing on top-tier hospitals in Beijing or Shanghai but warn about long wait times. Many advise using hospital apps to book appointments months in advance and bringing translated records.
Infliximab and Adalimumab are widely available and approved for treating moderate to severe Crohn’s disease in China. These biological drugs are included in the National Reimbursement Drug List. Patients can access the original brands or several local biosimilars at accredited medical facilities.
Bookimed Expert Insight: While many think only specialized oncology centers carry high-end medications, JCI-accredited facilities like Yanda International Hospital manage massive patient volumes reaching 2,500,000 annually. This scale often ensures a steady supply of complex biologics that smaller regional clinics may lack.
Patient Consensus: Patients note that getting approved for biologics can take 2 to 3 months for screenings. They recommend joining WeChat groups to find hospitals with current stock and English-speaking staff.
China integrates Traditional Chinese Medicine (TCM) as an adjuvant therapy alongside Western protocols. This dual approach combines biologics with specialized herbal decoctions and acupuncture. These therapies aim to regulate the brain-gut axis and improve local intestinal mucosal healing in patients.
Bookimed Expert Insight: Patient volume impacts integration quality significantly in China. Yanda International Hospital serves 2,500,000 patients every year. High-volume centers often possess more clinical experience in combining herbal decoctions with modern hormone therapies safely. Choosing JCI-accredited Class A level III facilities ensures standardized TCM formulas that meet rigorous safety criteria.
Patient Consensus: Patients note that combining standard biologics with hospital-vetted herbs leads to the best results. Many emphasize that following a doctor-led integrated protocol is safer than using standalone or unregulated herbal treatments.
Chinese clinics focus on stabilizing the spleen and stomach through a combined approach. Doctors emphasize warm, cooked foods like congee and bone broths to reduce internal inflammation. Patients often receive exclusive enteral nutrition (EEN) via liquid formulas to induce clinical remission during active phases.
Bookimed Expert Insight: Quality signals in China prioritize clinic classification over individual department size. Leading centers like Yanda International Hospital are designated as Class A Level III. This represents the high tier of Chinese healthcare complexity and technology. Patients should prioritize these JCI-accredited facilities when seeking integrated Western and Traditional Chinese Medicine (TCM) protocols.
Patient Consensus: Patients note that diets often include functional ingredients like goji berries and dates. Many find that shifting to warm, cooked meals provides more relief than standard Western bland diets.
Chinese medical centres treat Crohn's disease using an integrated approach. Doctors combine biological therapies and immunomodulators with traditional Chinese medicine. Care focuses on Class A Level III hospitals. These facilities offer endoscopy and specialised nutritional support during active disease flares.
Bookimed Expert Insight: China has thousands of hospitals. However, seeking treatment at Class A Level III facilities is vital. Yanda International Hospital in Beijing serves 2,500,000 patients annually and holds JCI accreditation. This designation means the facility meets rigorous global safety standards. These standards cover complex procedures like stricture dilation and endoscopic submucosal dissection.
Patient Consensus: Patients note that access to modern biologics is better in major urban tertiary hospitals. There is also better access to experienced IBD specialists. They recommend bringing complete medical records to avoid delays in treatment during consultations in China.
Chinese trials suggest combining Traditional Chinese Medicine with Western protocols improves remission rates. This integrated approach also lowers inflammatory markers. It typically pairs herbal therapies or acupuncture with conventional immunosuppressants. Studies show reduced C-reactive protein levels compared to using Western medicine alone.
Bookimed Expert Insight: While Chinese centres like Yanda International Hospital hold JCI accreditation, their Class A Level III status is the key quality marker. This tiering indicates a tertiary hospital capable of providing complex multidisciplinary care. Patients benefit from infrastructure that supports endoscopy and traditional Chinese wards in one facility.
Patient Consensus: Patients usually use traditional practices to ease pain or digestive issues. Chinese treatments are typically an adjunct to Western therapies rather than a replacement.
Chinese hospitals use biological therapies like Infliximab to treat moderate-to-severe Crohn's disease. Major tertiary centres also provide adalimumab, ustekinumab, and vedolizumab. Doctors typically prescribe these biologics when conventional therapies fail to manage inflammation or induce clinical remission.
Bookimed Expert Insight: While biologics are widely available in China, patient volume data shows concentrated expertise. Yanda International Hospital serves 2,500,000 patients annually across 39 departments. This high volume means specialists manage complex Crohn's cases daily. For Australians, choosing these large multidisciplinary centres provides the infrastructure for regular infusion cycles.
Patient Consensus: Patients note that access to specific biologics depends on the hospital's location. Major academic centres in coastal cities like Beijing or Shanghai offer the most consistent drug availability.
China hosts leading facilities for inflammatory bowel disease (IBD) such as JCI-accredited Yanda International Hospital and Renji Hospital. These Tier-3 Class A centres specialise in biological therapies, stem cell therapy, and faecal microbiota transplantation. Treatment protocols often involve modern gastroenterology and traditional Chinese medicine for complex cases.
Bookimed Expert Insight: While many centres focus on drug therapy, Yanda International Hospital stands out. It serves 2,500,000 patients annually using international protocols and traditional approaches. For Australians, this JCI-accredited hospital near Beijing offers a high-volume clinical environment. This scale often means specialists have handled more diverse refractory Crohn's cases than those in smaller regional centres.
International patients access high-level Crohn's disease care in China through Class 3 Grade A hospitals. These top-tier facilities, such as Yanda International Hospital, often hold JCI accreditation. Specialist gastroenterologists provide diagnostics like painless endoscopy and treatments ranging from hormone therapy to stem cell protocols.
Bookimed Expert Insight: Yanda International Hospital serves 2,500,000 patients annually and operates 39 dedicated departments. Massive patient volumes allow specialists to see rare Crohn's complications daily. Australian patients should note these high-capacity hubs often have 3,000 beds. This helps provide immediate inpatient care during flares.
Patient Consensus: Patients find it vital to confirm a dedicated inflammatory bowel disease unit exists. Many suggest requesting English discharge papers. This helps GPs manage medical follow-up back in Australia.
Managing Crohn's disease in China requires quitting smoking and strict dietary protocols like Exclusive Enteral Nutrition (EEN). Patients use structured exclusion diets to limit processed foods. Leading centres like Yanda International Hospital combine international protocols with traditional Chinese approaches. These JCI-accredited facilities use this dual approach to induce remission.
Bookimed Expert Insight: China's top-tier hospitals often integrate multidisciplinary teams. Yanda International Hospital serves over 2,500,000 patients annually using Class A Level III standards. This high volume allows specialists like Dr Sun Guanxi to specialise in painless, sedated endoscopy. These procedures make regular monitoring more comfortable for international patients.
Patient Consensus: Patients emphasise being strict about food safety and hydration when travelling through China. They suggest carrying a translated medical summary. This helps local doctors understand specific flare-up histories immediately.